All PlansCoverageMedium impact

Newsletter Vol. 16, No. 02

Q: Who is affected by this change?

This affects New Jersey Medicaid Pain Management, Psychiatry, Addiction Medicine, Family Medicine, Internal Medicine providers in NJ on All Plans plans.

New Jersey Medicaid·NJ · Pain Management, Psychiatry, Addiction Medicine +2 more·Pharmacy

Effective date

Not stated

We identified it

Jun 20, 2026

Days to comply

—

Summary

Newsletter Vol. 16, No. 02 addresses methadone-narcotic drug use policies within the MEP (Medical Expense Program). This policy update likely affects billing and coverage requirements for methadone treatment and related narcotic drug services.

Action Required

Action needed

Review Newsletter Vol. 16, No. 02 from the source URL to understand specific changes to methadone and narcotic drug billing requirements within the MEP program. Billing team should download and analyze the full policy document to identify any new prior authorization requirements, coverage limitations, or documentation needs for methadone-related services.

Related policy hubs

New Jersey Medicaid policies NJ policy changes Pain Management Psychiatry Addiction Medicine Family Medicine Internal Medicine